{"celex_id": "32010D1215(02)", "uri": "http://publications.europa.eu/resource/cellar/377e65eb-d321-49d5-addb-cff9b83ae5cf", "type": "Decision", "concepts": ["115", "3559", "4038", "5426"], "title": "Commission Decision of 14\u00a0December 2010 appointing two Commission representatives and two alternates to the Management Board of the European Medicines Agency\n", "header": "15.12.2010 EN Official Journal of the European Union C 340/17\nCOMMISSION DECISION\nof 14 December 2010\nappointing two Commission representatives and two alternates to the Management Board of the European Medicines Agency\n2010/C 340/10\nTHE EUROPEAN COMMISSION", "recitals": ",\nHaving regard to the Treaty on the Functioning of the European Union,\nHaving regard to Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency\u00a0(1), and in particular Article 65 thereof,\nWhereas:\n(1) Pursuant to Article 65 of Regulation (EC) No 726/2004, the Management Board of the European Medicine Agency (hereinafter \u2018the Agency\u2019) is to include two representatives of the Commission.\n(2) Due to reallocation of competences within the Commission, it is necessary to appoint two new members of the Management Board of the Agency from the Directorate-General for Health and Consumers and from the Directorate-General for Enterprise and Industry and two alternates who will replace the members in their absence and vote on their behalf,", "main_body": ["The representatives of the Commission to the Management Board of the European Medicines Agency shall be the persons occupying the following positions and exercising the following functions:\nFrom the Directorate-General for Health and Consumers:\n(a) Director-General of the Directorate-General for Health and Consumers.\nThe alternate representative shall be the person occupying the following position and exercising the following functions:\n(b) Director heading the Directorate which is responsible for the authorisation of medicinal products on the basis of the work program of the Directorate-General for Health and Consumers.\nFrom the Directorate-General for Enterprise and Industry:\n(c) Director heading the Directorate which is responsible for pharmaceuticals on the basis of the work program of the Directorate-General for Enterprise and Industry.\nThe alternate representative shall be the person occupying the following position and exercising the following functions:\n(d) Head of Unit heading the Unit responsible for pharmaceuticals on the basis of the work program of the Directorate-General for Enterprise and Industry.", "This Decision shall apply to the persons occupying, including on a temporary basis, the positions referred to in Article 1 at the date of adoption of this Decision, or to any successor of those persons in those positions.", "The Director-Generals of the Directorate-General for Health and Consumers and the Directorate-General for Enterprise and Industry shall inform the President of the Management Board and the Executive Director of the Agency of the names of the persons occupying the positions referred to in Article 1, and any changes thereof."], "attachments": "Done at Brussels, 14 December 2010.\nFor the Commission\nJohn DALLI\nMember of the Commission\n(1)\u00a0\u00a0OJ L 136, 30.4.2004, p. 1."}